New York Eye and Ear Infirmary
New York, 10003, United States
NCT Number: NCT01712555
After people lose an eye, for whatever reason, they often experience fat atrophy of the tissues in the orbit. This leads to a sunken appearance that is often not correctable by a cosmetic shell prosthesis. Current techniques to correct this deformity are inadequate/ invasive. Injection of various gels (Restylane, Radiesse) are temporary had have their own disadvantages. This study seeks to demonstrate an improvement in the retention of injected autologous fat by mixing in autologous PRP (platelet rich plasma).
Looking for future studies?
Notify Me21 year–70 year
All sexes
Interventional
Not applicable
New York, 10003, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
anophthalmos, orbital atrophy -
Exclusion criteria
poor anesthesia risk, people outside a 100 mile radius of New York City
-
Time frame: 1-5 yrs
Non contrast MRIs of the orbits are obtained before, immediately after, and one year after injection of autologous fat mixed with autologous PRP (platelet rich plasma)
Fox, Donald Munro, M.D., P.C.
Indiv
Autologous Fat Grafting to Anophthalmic Sockets With PRP (Platelet Rich Plasma) Using a Closed Cannula Technique
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02244671
Orbital Atrophy
New York, United States
View Trial DetailsNCT04395404
Anophthalmic Socket Syndrome, Anophthalmos
Leuven, Belgium
View Trial DetailsNCT04321382
Anophthalmos, Anophthalmos, Unilateral
Leuven, Belgium
View Trial DetailsNCT00011843
Anophthalmos, Congenital Abnormalities
Bethesda, Maryland, United States
View Trial Details